Evidence map›Paper›PMID 42871554›Full record

ArticleJAAD case reports2026

Deucravacitinib in concomitant psoriasis vulgaris and bullous pemphigoid: A case of sustained dual disease control.

Rachel Daher, Alessandro Magnatta, Walter Volpi, Luca Sanna, Virginia Corti, Simone Landini, Irene Bonanni, Marta Donati, Alice Verdelli, Marzia Caproni

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JAAD case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rachel DaherDepartment of Dermatology, Università degli Studi di Firenze, Piazza di San Marco, Florence, Italy.
Alessandro MagnattaDepartment of Dermatology, Università degli Studi di Firenze, Piazza di San Marco, Florence, Italy.
Walter VolpiDepartment of Dermatology, Università degli Studi di Firenze, Piazza di San Marco, Florence, Italy.
Luca SannaDepartment of Dermatology, Università degli Studi di Firenze, Piazza di San Marco, Florence, Italy.
Virginia CortiDepartment of Dermatology, Università degli Studi di Firenze, Piazza di San Marco, Florence, Italy.
Simone LandiniDepartment of Dermatology, Università degli Studi di Firenze, Piazza di San Marco, Florence, Italy.
Irene BonanniDepartment of Dermatology, Università degli Studi di Firenze, Piazza di San Marco, Florence, Italy.
Marta DonatiDepartment of Dermatology, University of Modena and Reggio Emilia, Modena, and Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Skin Cancer Centre, Reggio Emilia, Italy.
Alice VerdelliDepartment of Dermatology, Rare Skin Diseases Unit, P.O. Piero Palagi, A USL Toscana Centro, ERN-SKIN Member, University of Florence, Florence, Italy.
Marzia CaproniDepartment of Dermatology, Rare Skin Diseases Unit, P.O. Piero Palagi, A USL Toscana Centro, ERN-SKIN Member, University of Florence, Florence, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

autoimmune blistering diseasesbullous pemphigoiddeucravacitinibpsoriasistyrosine kinase 2

Identifiers

PMID42871554
PMCPMC13659480

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.